CPT-Se3 exhibits potent anticancer activity by effectively killing cancer cells and inhibiting tumor growth; it induces apoptosis in cancer cells by decreasing the GSH/GSSG ratio and total thiols, and increasing ROS levels in HepG2 cells; it shows cytotoxicity against HeLa, HepG2, A549, and SMMC-7721 cancer cell lines (IC50 = 2.19–4.7 μM).